Skip to main content
. 2020 Feb 6;10(2):14. doi: 10.1038/s41408-020-0283-8

Fig. 1. Study flowchart.

Fig. 1

From the starting population (n = 413), 92 patients were excluded. Hence, molecular profiling and survival analyses were performed with 327/413 patients (79.2%).